Independent · NAD⁺ only
Compare NAD⁺ injections, IV therapy and supplements by evidence, published price and what you receive.
Published methodology. Clearly labeled partnerships. Evidence and prices you can check.
Subcutaneous NAD⁺ from telehealth prescribers — what a course actually costs, who ships it, and what the dosing evidence supports.
Explore →ivThe most expensive way to raise NAD⁺ and the one with the least outcome data. We price it honestly and say so.
Explore →oralNR and NMN reliably raise blood NAD⁺ in randomized trials and cost a fraction of a drip. The evidence ranking is the inverse of the price ranking.
Explore →Controlled NAD⁺ and NR trials in heart failure exist. Their results separate early cardiac and blood-marker findings from unproven long-term treatment benefits.
Three small randomized NR trials raised interest in brain biomarkers, but none established better cognition. Here is what the measured outcomes show.
Early NR trials showed biological activity and short-term tolerability in Parkinson’s disease. They did not establish slower disease progression.
We distinguish studies of oral precursors from studies of NAD⁺ injections and IV therapy. A rise in NAD⁺ is not proof of a health benefit.
Partners appear first and are labeled. A commercial relationship does not change our assessment.
Compare the seller’s price, billing period and dose. Missing details are a reason to ask before paying.
We rank providers on evidence and transparency. Commercial relationships set the order of partners — never the verdict.
Disclosure: NAD Picks is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. Partners are listed first; commissions do not change evidence scores or editorial verdicts. How we make money.
NAD+
Sells NAD⁺ three ways with the tablet priced below the other two, behind a catalog that renders only in the browser — the server sends a page saying no products were found.
NAD+
States a monthly milligram total, sells a genuine single month rather than only prepaid terms, and calls its own NAD⁺ investigational and not FDA-approved on the product page itself.
NAD+
Prints the milligrams beside the price on both its plans, which is rare here — and the arithmetic that makes possible shows the cheaper plan costing about 60% more per milligram than the larger one.